Alcanza Clinical Research

Cardiology research sites face challenges that are often best solved together. Alcanza's Neil Sheth, MD, FNLA, Regional Medical Director, New Site Operations and Principal Investigator, will join Michele Cameron, BSN, MBA, CCRC and Debra Rogge in leading the the Cardiology Round Table at the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit. This guided discussion gives sites a space to share experiences and work through questions specific to #cardiovascular research. TA Round Table: Cardiology Friday, October 16 3:30 to 4:30 pm ET Taylor room Visit Alcanza at Booth 606 | October 15 - 18 | Orlando

Resilience against market volatility is a hot topic in clinical research. We invite you to join this session at SCRS with Carlos E. Orantes to discuss building a proactive strategy to future-proof your site. Learn to track the operational and financial metrics that predict future capacity: backlog health, feasibility volume, pipeline velocity, and activation timelines. Identify early warning signs of declining opportunities, develop response strategies that protect revenue and staffing, and make data-driven decisions about resource allocation and therapeutic diversification. Leave with practical tools for scenario planning and long-term resilience. Join the discussion: Future-Proofing Your Site: Forecasting & Resilience Breakout Session II 1:30 pm – 2:30 pm Flagler/Gilchrist Society for Clinical Research Sites (SCRS) Global Summit #SCRS2026

A strong Alcanza team is heading to SCRS Global - including a colorful new member you haven't met yet!* We always look forward to this annual reconnecting of partners and colleagues giving voice to the site perspective. If you’ll be attending, reach out to any of our team members: Carlos E. Orantes, CEO Karim C. Chalhoub, President & COO Casey Orvin, CCO Dori Sarkis, Partnerships Rachel Benz, Early Phase Rachel Lyons, Partnerships Alberto Blanco, Partnerships Ashley Rich, Partnerships Margaret White, Partnerships Neil Sheth, MD, FNLA, Regional Medical Director Susan Angel, MSN, APRN, Clinical Operations Nathan Morton, Former Owner, Coastal Carolina Research Dan Kearney, Former Owner, CNS Healthcare Please email bd@alcanzaclinical.com to arrange a personal meeting. *Hint: someone bold, bright, and a little unexpected is making the flight to Orlando this year. Visit our booth or keep an eye out walking through the exhibit hall - you'll know them when you see them! Society for Clinical Research Sites (SCRS) Global Orlando, FL | October 2026 | Booth 606 #SCRS2026 #SCRS

Action shot from the stage in Boston today at Partnerships with Sites with Carlos E. Orantes and Jonathan Moshinsky of Stitch. Their discussion, "Show Up, Stay In, Come Back: The Untapped Economics of Patient Experience" centered on the intricacies of reducing patient no-show and dropout rates by identifying high-intent participants, enhancing their experience, and creating pathways for them to enroll beyond a single trial. #patientrecruitment #clinicalresearch

What truly makes your site memorable? Dori Sarkis will be leading a conversation among industry colleagues and sharing some of the unique value-drivers we see across the Alcanza site network. Move beyond generic metrics to showcase what makes your organization unique: retention strategies, community ties, operational approaches. Hear from standout sites about what actually breaks through the noise, then refine your elevator pitch with narrative elements that make your site stand out. Join us for this breakout session at SCRS Global: Define Your Difference: Showcasing Your Site's Unique Value Saturday, October 17, 2026 3:30 pm – 4:30 pm Collier/Columbia Breakout SCRS | Orlando, FL We invite you to join in the discussion and discover how to showcase your own site's unique values. Society for Clinical Research Sites (SCRS)

Boston is calling! Carlos E. Orantes and Dori Sarkis will be attending Partnerships with Sites and DPHARM, and are optimistic about what’s ahead for sites, sponsors, and better clinical trial partnerships. We're looking forward to some great conversations focused on strengthening site partnerships and improving clinical trial delivery. Want to find time to meet? Reach out to BD@alcanzaclinical.com to schedule a personal meeting on site. Partnerships with Sites Summit + DPHARM | September 14-16, 2026 | Boston, MA Fierce Biotech Partnerships with Sites DPHARM: Disruptive Innovations to Modernize Clinical Trials

Inspection readiness isn't something you scramble for two weeks out. The sites that walk into audits calm are the ones who built readiness into how they work every day, not the ones with the thickest binder. Join a webinar with research professionals who've been through it. Leah Marie Kesler, Erin Gainey, and Luke Atwill will share what actually held up under inspection, what they'd do differently, and how they use Florence Healthcare to keep documentation audit-ready without the last-minute fire drill. Been There, Passed That: Inspection Readiness Tips & Tricks Wednesday, Sep 9 | 12 PM ET | 9 AM PT Before your next audit or inspection, learn how to: 1. Build processes that keep your site inspection-ready year-round, not just during prep 2. Know exactly where your documentation stands at any moment, and spot gaps before an auditor does. 3. Handle the inspection itself with more confidence and fewer surprises Join the webinar: https://lnkd.in/gvkrAByf

Do you have a "future-proof" strategy that protects your site against market volatility? If you're heading to Society for Clinical Research Sites (SCRS) Global Summit, don't miss this breakout session! This expert leadership team will share their practical insights and lead discussion on how to build a proactive strategy that protects your site from market distruptions: Carlos E. Orantes, CEO of Alcanza Chris Hoyle, Founder and CEO at Elite Research Network Bailey Jordan, Sr. Manager, Site Development at Worldwide Clinical Trials Jason Layton, CGO at Headlands Research Learn to track the operational and financial metrics that predict future capacity: backlog health, feasibility volume, pipeline velocity, and activation timelines. Identify early warning signs of declining opportunities, develop response strategies that protect revenue and staffing, and make data-driven decisions about resource allocation and therapeutic diversification. Future-Proofing Your Site: Forecasting & Resilience Saturday, October 17, 2026 Breakout Session II Flagler/Gilchrist 1:30 pm – 2:30 pm We invite you to join in the discussion! #SCRS2026 #ClinicalTrials #Feasibilty #Pipeline

Quest Research Institute, part of the Alcanza Clinical Research network, is proud to be preparing for upcoming clinical research with Aspen Neuroscience as the field continues to advance innovative approaches to Parkinson’s disease.   A new milestone in Parkinson’s research: Aspen Neuroscience, Inc. recently received an FDA designation for its investigational cell therapy for Parkinson’s disease. While this designation is not FDA approval, it represents continued progress in the exploration of regenerative medicine and potential future treatment approaches for people living with Parkinson’s.   Announcements like these highlight the importance of clinical research in advancing scientific discovery and creating new possibilities for patients and families affected by neurological disease.   We look forward to supporting this important area of research and contributing to the future of Parkinson’s innovation. #ParkinsonsDisease #ClinicalResearch #ResearchInnovation #RegenerativeMedicine #AlcanzaClinicalResearch #QuestResearchInstitute

Alcanza's Carlos E. Orantes will join Jonathan Moshinsky of Stitch for a discussion on fine-tuning the patient experience for improved retention at the upcoming Partnerships with Sites! High screening no-show rates and patient dropout remain persistent challenges across clinical research. This session examines how sponsors, CROs, and sites can improve enrollment and retention by identifying high-intent participants, enhancing the patient experience, and creating pathways for ongoing patient engagement beyond a single trial. Join Carlos and Jonathan at 11:25am - 11:40am during the General Session track. September 14, 2026 | Boston